4//SEC Filing
Bruck Claudine 4
Accession 0001104659-24-077831
CIK 0001477845other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:15 PM ET
Size
5.8 KB
Accession
0001104659-24-077831
Insider Transaction Report
Form 4
Bruck Claudine
Director
Transactions
- Award
Stock Option (right to buy)
2023-11-17+26,200→ 26,200 totalExercise: $6.07Exp: 2033-11-17→ Common Stock (26,200 underlying)
Footnotes (2)
- [F1]On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved.
- [F2]The stock option shall vest immediately upon grant date.
Documents
Issuer
Annovis Bio, Inc.
CIK 0001477845
Entity typeother
Related Parties
1- filerCIK 0001733680
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 5:15 PM ET
- Size
- 5.8 KB